AAP
RCUS icon

Arax Advisory Partners’s Arcus Biosciences RCUS Stock Holding History

Arax Advisory Partners’s Portfolio RCUS Stock Details RCUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$41.1K Buy
+1,333
New +$32.9K ﹤0.01% 3431
2026
Q1 		– Sell
-162
Closed -$3.86K – 4229
2025
Q4 		$3.86K Sell
162
-1,224
-88% -$25K ﹤0.01% 2987
2025
Q3 		$18.9K Buy
+1,386
New +$14.4K ﹤0.01% 2286

Other funds holding RCUS

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Arax Advisory Partners's RCUS Position: Q2 2026 in Review

Arax Advisory Partners opened a new position in Arcus Biosciences (RCUS) in Q2 2026: 1,333 shares worth $41.1K. The stake represents ﹤0.01% of the portfolio and ranks #3431 among its holdings. This is a return to the name: Arax Advisory Partners previously reported a position in RCUS as recently as Q4 2025.

Arax Advisory Partners first reported a position in RCUS in Q3 2025 and has held it in 3 quarters since. 230 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.

  • Arax Advisory Partners held 1,333 shares of Arcus Biosciences worth $41.1K as of Q2 2026.
  • Arcus Biosciences was a new Arax Advisory Partners position in Q2 2026.
  • Arcus Biosciences made up ﹤0.01% of Arax Advisory Partners's portfolio in Q2 2026, its #3431 holding.
  • Arax Advisory Partners first reported a position in Arcus Biosciences in Q3 2025 and has held it in 3 quarters since.
  • 230 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.

Based on Arax Advisory Partners's 13F filing for Q2 2026, filed 10 Aug 2026.